← All stocks

Oruka Therapeutics, Inc.

ORKA Mostly scheduled
CIK 0000907654 #1126 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$332.56M
$2.66M on a plan · $329.12M straight out of an exercise
Sold at will
$777.00K
10 of 100 sales
Net
−$332.56M
−$777.00K against sales at will

By person

9 insiders · 100 transactions
141×

Lawrence Klein holds 141 times base salary in stock. $88.35M of shares against $624.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Lawrence Klein last reported holding, valued at $95.71, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Fairmount Funds Management LLC entity
Director
$300.01M (1) scheduled
−$300.01M
1,131,954
1.71%
$108.34M
+77.3%
Dambkowski Carl
Director
$8.65M (5) scheduled
−$8.65M
38,743
0.0585%
$3.71M
Klein Lawrence Otto
Chief Executive Officer
$7.31M (6) scheduled
−$7.31M
923,128
1.39%
$88.35M
+8.3%
Quinlan Paul T
General Counsel
$5.82M (9) scheduled
−$5.82M
29,995
0.0453%
$2.87M
Goncalves Joana
Chief Medical Officer
$4.54M (35) scheduled
−$4.54M
31,771
0.0480%
$3.04M
+1,659%
Agarwal Arjun
Senior Vice President, Finance
$4.28M (25) scheduled
−$4.28M
14,752
0.0223%
$1.41M
+457.5%
Sandler Laura Lee
Chief Operating Officer
$1.94M (19) scheduled
−$1.94M
235,478
0.3557%
$22.54M
+10.5%
Venrock Healthcare Capital Partners III, L.P. entity
10% owner
4,148,428
6.27%
$397.05M
+3.1%
Edwards Larry Todd
Chief Commercial Officer
100,000
0.1510%
$9.57M

Nothing of that kind in this period.

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 84
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 4,625,943
History held since 21 Sep 2016